monday.com Ltd. (MNDY) Market Cap & Valuation Ratios
monday.com Ltd. (MNDY) has a market cap of $4.5B, a trailing P/E of 45.1 and a price-to-sales ratio of 3.3, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MNDYmonday.com Ltd.Follow MNDY — free
—
Price chart with a free account
- Market cap
- 4.5B
- P/E TTM
- 45.1
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
Peers
software - application · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| MNDY | 4.5 | 45.1 | 2.5 | 103.3 | 6.6% | +24% | 1% | — |
| MBLY | 5.5 | — | 2.1 | — | 7.1% | +5% | -207% | -48% |
| BB | 5.2 | 70.5 | 8.2 | 50.9 | 1.8% | +14% | 14% | 11% |
| BRZE | 5.2 | — | 6.0 | — | 1.5% | +27% | -13% | -23% |
| WK | 4.7 | 103.4 | 4.8 | 110.0 | 4.3% | +20% | 3% | 7% |
| DAVE | 4.5 | 23.0 | 7.1 | 20.4 | 7.1% | +49% | 33% | 64% |
| CCC | 4.5 | 97.6 | 5.1 | 17.4 | 6.8% | +12% | 16% | 5% |
| QTWO | 4.3 | 49.6 | 5.0 | 31.3 | 4.4% | +14% | 10% | 13% |
| BILL | 4.3 | — | 2.6 | 98.0 | 8.2% | +13% | -4% | -2% |
| FRSH | 4.0 | — | 3.7 | 56.7 | 5.5% | +16% | 3% | 5% |
| FSLY | 3.9 | — | 5.6 | — | 0.9% | +20% | -12% | -7% |
| Median of these 10 | 70.5 | 5.1 | 50.9 | 4.9% | +15% | 3% | 5% |
P/E 45.1 vs. a peer median of 70.5; EV/Sales 2.5 vs. 5.1.
Growth vs. price
each dot a company · hover or tap for valuesMBLY and BRZE and BILL and FRSH and FSLY have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
monday.com Ltd. — questions
- What is monday.com Ltd.'s market cap?
- $4.5B.
- What is monday.com Ltd.'s P/E ratio?
- 45.1 on trailing twelve-month earnings to 2026-06-30.
- What is monday.com Ltd.'s price-to-sales ratio?
- 3.3.
Every figure on this page comes from monday.com Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.